HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christelle de la Fouchardiere Selected Research

Christelle de la Fouchardiere Research Topics

Disease

7Neoplasms (Cancer)
01/2023 - 07/2014
6Colorectal Neoplasms (Colorectal Cancer)
03/2023 - 01/2016
6Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 08/2011
3Microsatellite Instability
03/2023 - 12/2020
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2020
3Adenocarcinoma
01/2021 - 01/2020
3Disease Progression
01/2021 - 07/2014
3Fatigue
01/2020 - 09/2012
2Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 12/2020
2Neoplasm Metastasis (Metastasis)
01/2016 - 09/2012
1Adrenocortical Carcinoma
01/2023
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2023
1Stomach Neoplasms (Stomach Cancer)
01/2021
1Spasm (Spasms)
01/2020
1Hyponatremia
01/2020
1Follicular Adenocarcinoma
02/2016
1Papillary Thyroid Cancer
02/2016
1Hypertension (High Blood Pressure)
01/2016
1Diarrhea
01/2016
1Anorexia
01/2016
1Mucositis
01/2016
1medullary Thyroid cancer
04/2015
1Cardiotoxicity
04/2015
1Exanthema (Rash)
07/2014
1Alopecia (Baldness)
07/2014
1Pheochromocytoma
10/2013
1Paraganglioma (Paragangliomas)
10/2013
1Asthenia
09/2012
1Pneumonia (Pneumonitis)
09/2012

Drug/Important Bio-Agent (IBA)

4pembrolizumabIBA
03/2023 - 12/2020
3Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2020
3Docetaxel (Taxotere)FDA Link
01/2022 - 01/2020
3Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 01/2020
2Bevacizumab (Avastin)FDA Link
03/2023 - 12/2020
2Cetuximab (Erbitux)FDA Link
03/2023 - 12/2020
2lenvatinibIBA
01/2022 - 11/2016
2Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 12/2020
2regorafenibIBA
01/2016 - 01/2016
2vandetanib (ZD6474)IBA
04/2015 - 09/2012
1SDMIBA
01/2023
1neratinibIBA
01/2023
1Mitotane (Lysodren)FDA Link
01/2023
1B7-H1 AntigenIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1NivolumabIBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Exonucleases (3' 5' Exonuclease)IBA
01/2022
1RamucirumabIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1Irinotecan (Camptosar)FDA LinkGeneric
12/2020
1130-nm albumin-bound paclitaxelIBA
01/2020
1GemcitabineFDA Link
01/2020
1Hyaluronic Acid (Hyaluronan)IBA
01/2020
1PEGPH20IBA
01/2020
1RacivirIBA
02/2016
1prolinedithiocarbamate (PDTC)IBA
02/2016
1Tyrosine Kinase InhibitorsIBA
02/2016
1IodineIBA
07/2014
1Sorafenib (BAY 43-9006)FDA Link
07/2014

Therapy/Procedure

9Therapeutics
01/2023 - 08/2011
7Drug Therapy (Chemotherapy)
03/2023 - 12/2020
2Immunotherapy
01/2022 - 01/2021